Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

ONO Pharmaceutical

Main (gene editing) focus: Next-generation cell therapies

Company stage: Commercial

Diseases: Cancer

Genome editing tool: CRISPR

Funding stage: Public (OTC:OPHLY)

Location: Osaka, Osaka, Japan

Website: https://www.ono-pharma.com/

Pipeline: https://www.ono-pharma.com/ir/library/pipeline.html

Partners: Fate Therapeutics

ONO Pharmaceutical is a global pharmaceutical company headquartered in Japan. The company's engagement in the gene-editing space comes through its collaboration with Fate Therapeutics. The two companies will develop multiple off-the-shelf cell therapies incorporating multiple gene edits.

Tags

HashtagONO Pharmaceutical Co., Ltd

Company: ONO Pharmaceutical
close
Search CRISPR Medicine